Table 2.
Kinetics of depolarization-triggered [Ca2+]i transients in δ-cells
[cAMP]i (μM)Treatment[Ca2+]peak (nM)Half width (ms)n
n/a 185 ± 60 226 ± 30 
n/a 347 ± 88 207 ± 17 
10 n/a 326 ± 35 282 ± 17 
100 n/a 353 ± 56a 347 ± 36a 
100 µM 2′-O-Me-cAMP 232 ± 34b 465 ± 121a 
100 10 µM thapsigargin 286 ± 45 301 ± 12 
100 1 µM myr-PKI 347 ± 53a 558 ± 106a 
100 25 µM ESI-05 225 ± 39 291 ± 34 
[cAMP]i (μM)Treatment[Ca2+]peak (nM)Half width (ms)n
n/a 185 ± 60 226 ± 30 
n/a 347 ± 88 207 ± 17 
10 n/a 326 ± 35 282 ± 17 
100 n/a 353 ± 56a 347 ± 36a 
100 µM 2′-O-Me-cAMP 232 ± 34b 465 ± 121a 
100 10 µM thapsigargin 286 ± 45 301 ± 12 
100 1 µM myr-PKI 347 ± 53a 558 ± 106a 
100 25 µM ESI-05 225 ± 39 291 ± 34 

Peak ([Ca2+]peak) and duration (half width) of [Ca2+]i transients triggered by 300-ms depolarizations from −70 mV to 0 mV in δ-cells infused with intracellular solutions containing cAMP with concentrations indicated. The Treatment column lists the compounds that were infused into δ-cells at the indicated concentrations in the presence of 100 µM cAMP (with the exception of thapsigargin, which was applied extracellularly during the pretreatment of the islets). Data are presented as mean values ± SEM of indicated number of independent experiments (n) from two to eight animals. All the measurements were made using standard whole-cell technique. n/a, not applicable.

a

P < 0.05 vs. control (no addition of cAMP).

b

P < 0.05 vs. 100 µM cAMP alone.

or Create an Account

Close Modal
Close Modal